Current Cancer Drug Targets, Volume 15 - Number 5

Meet Our Editorial Board Member:

, 15(5): 363

Daniel M. Raben

DOI: 10.2174/156800961505150710112704

Notch Signaling in Cancer: Rationale and Strategies for Targeting

, 15(5): 364 - 374

Aisha Alketbi and Samir Attoub

DOI: 10.2174/156800961505150710113353

Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors

, 15(5): 375 - 393

Sailu Sarvagalla and Mohane Selvaraj Coumar

DOI: 10.2174/1568009615666150421110401

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer

, 15(5): 394 - 405

Ryan Stuchbery, Natalie J. Kurganovs, Patrick J. McCoy, Colleen C. Nelson, Vanessa M. Hayes, Niall M. Corcoran and Christopher M. Hovens

DOI: 10.2174/1568009615666150416113453

Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy

, 15(5): 406 - 422

Yaping Jiang, Wei Fei, Xiao Cen, Yaling Tang and Xinhua Liang

DOI: 10.2174/1568009615666150407125333

An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model System

, 15(5): 423 - 434

Xiaohong Han, Manjiao Liu, Shuai Wang, Guanting Lv, Li Ma, Changqing Zeng and Yuankai Shi

DOI: 10.2174/1568009615666150416122422

Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)

, 15(5): 435 - 444

Angela Lamarca, Marta Mendiola, Elsa Bernal, Victoria Heredia, Esther Díaz, María Miguel, Laura G. Pastrian, Emilio Burgos, Jaime Feliu and Jorge Barriuso

DOI: 10.2174/1568009615666150407124747

Nanoradiopharmaceuticals for Bone Cancer Metastasis Imaging

, 15(5): 445 - 449

Bianca Feliciano Coelho, Marta de Souza Albernaz, Alexandre Iscaife, Katia Ramos Moreira Leite, Mara de Souza Junqueira, Emerson Soares Bernardes, Emerson Oliveira da Silva and Ralph Santos-Oliveira

DOI: 10.2174/1568009615666150407125020

Webmaster Contact:
Copyright © 2018 Bentham Science